Bayer AG (BAYN.DE) shares climbed significantly in midday trading, pushing the company to the top of the DAX index.
Deutsche Bank has raised its price target for Bayer AG, marking the first upward revision for the pharmaceutical giant this week.
The move reflects growing investor confidence in the company's near-term trajectory, supported by positive commentary from major banks.
Bayer's stock performance has been bolstered by a combination of favorable analyst sentiment and structural market interest.